skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Managing insulin resistance: role of liraglutide

Mini-review

(2994) Views  (1075) Full article downloads

Authors: Sanjay Kalra, Bharti Kalra, Satish Kumar, et al

Published Date June 2010 Volume 2010:2 Pages 131 - 134
DOI: http://dx.doi.org/10.2147/CPAA.S10496

Sanjay Kalra1, Bharti Kalra1, Satish Kumar2, Amit Sharma1

1Department of Endocrinology, Bharti Hospital, Karnal, India; 2Department of Clinical Operations, Excel Life Sciences, Noida, India

Abstract: Diabetes mellitus is part of the insulin resistance syndrome, which includes hypertension, dyslipidemia, and obesity as its other components. Conversely, insulin resistance is a major pathophysiologic factor in the development of type 2 diabetes. It makes sense, therefore, to choose an anti-diabetic medication that acts on insulin resistance and its clinical components, while having anti-hyperglycemic effects as well. This review discusses the non-glycemic, or extra-pancreatic effects, including insulin sensitization, of liraglutide, a novel GLP-1 analog.

Keywords: liraglutide, GLP-1 analog, weight modulation, systolic blood pressure, cardioprotection, insulin resistance






 

Other articles by Dr S Kalra



Readers of this article also read:
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University